Gufic Biosciences Ltd

GUFICBIO

Company Profile

  • Business description

    Gufic Biosciences Ltd is engaged in the manufacturing and marketing of active pharmaceutical ingredients, generic pharmaceuticals, and related services. Geographically, it derives a majority of revenue from India. Its product portfolio includes Criticare, Criticare Life, Ferticare, Spark, Herbal, and other products. The company's lyophilized product includes antibiotics, anti-fungal, cardiac, infertility, anti-viral, and a proton-pump inhibitor. It derives maximum revenue from India.

  • Contact

    SM House, 11 Sahakar Road
    1st to 4th Floor
    Vile Parle (East)
    MumbaiMH400 057
    IND

    T: +91 2267261000

    https://www.gufic.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - Specialty & Generic

    Fiscal Year End

    31 March 2026

    Employees

    2,926

Stocks News & Analysis

stocks

ASX listed software provider joins global sell-off

Our thesis remains unchanged.
stocks

AMD earnings: Data center demand still looks quite strong to us

AMD has the components to target $100 billion of AI revenue in the next few years.
stocks

PayPal earnings: Growth slows, new CEO appointed

We expect to lower our fair value estimate of PayPal stock.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,149.0031.90-0.35%
CAC 408,262.1682.661.01%
DAX 4024,603.04177.75-0.72%
Dow JONES (US)49,501.30260.310.53%
FTSE 10010,402.3487.750.85%
HKSE26,555.74291.58-1.09%
NASDAQ22,904.58350.61-1.51%
Nikkei 22553,898.35395.01-0.73%
NZX 50 Index13,452.2415.05-0.11%
S&P 5006,882.7235.09-0.51%
S&P/ASX 2008,882.8021.20-0.24%
SSE Composite Index4,062.2140.00-0.97%

Market Movers